ArticleRSC advances2024

Development of NHAcGD2/NHAcGD3 conjugates of bacteriophage MX1 virus-like particles as anticancer vaccines.

Qingyu Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.